VERA Stock — Vera Therapeutics, Inc.: Metrics

Market overview

2 metrics

Share price

$35.66

Market cap

$2.49B

Price action

19 metrics

Price change (1W)

-3.0%

Price change (30D)

+6.2%

Price change (3M)

+9.5%

Price change (6M)

-12.9%

Price change (YTD)

-32.4%

Price change (1Y)

+58.2%

Trailing year

Price change (5Y)

+112.1%

52-week high

$55.67

52-week low

$21.90

Change from 52-week high

-38.5%

Change from 52-week low

+56.3%

Annualized volatility

60.2%

Beta

1.1

RSI (14D)

51.7

Price vs SMA 50

-5.2%

Price vs SMA 200

-13.0%

Avg volume (3M)

2.12M

Relative volume

1.9

Average dollar volume

$77.07M

Company

3 metrics

Sector

Healthcare

Industry

Biotechnology

Shares outstanding

72.06M

Valuation

12 metrics

P / E (TTM)

—

Trailing earnings

PEG ratio

—

EV / revenue

—

EV / EBITDA

—

EV / EBIT

—

P / sales

—

P / book

6.0

reciprocal yield 16.5%

FCF yield

-13.8%

TTM · current market cap

Buyback yield

—

P / FCF

—

P / operating cash flow

—

Earnings yield

-16.3%

Historical valuation

8 metrics

P / E historical average (3Y)

—

P / E historical average (5Y)

—

EV / revenue historical average (3Y)

—

EV / revenue historical average (5Y)

—

EV / EBIT historical average (3Y)

—

EV / EBIT historical average (5Y)

—

EV / EBITDA historical average (3Y)

—

EV / EBITDA historical average (5Y)

—

Dividends & buybacks

7 metrics

Dividend yield

—

Trailing 12 months

Payout ratio

—

Shareholder yield

—

Dividend / share (TTM)

—

Dividend growth YoY

—

Dividend growth streak

—

Last ex-dividend

—

Earnings calendar

2 metrics

Next earnings

—

Last earnings

2025-11-05

Profitability

9 metrics

Gross margin

—

Operating margin

—

Trailing 12 months

Net margin

—

Gross profit (TTM)

—

Operating profit (TTM)

−$415.76M

Net income (TTM)

−$401.89M

Trailing 12 months

Diluted EPS (TTM)

$-5.86

FCF margin

—

Effective tax rate

—

Per share

11 metrics

Revenue per diluted share (TTM)

—

Gross profit per diluted share (TTM)

—

Operating profit per diluted share (TTM)

—

EBITDA per diluted share (TTM)

—

Net income per diluted share (TTM)

—

Operating cash flow per diluted share (TTM)

—

Free cash flow per diluted share (TTM)

—

Capital expenditures per diluted share (TTM)

—

R&D per diluted share (TTM)

—

Stock compensation per diluted share (TTM)

—

Book value per share

—

Growth

11 metrics

Revenue growth YoY

—

Year over year

Net income growth YoY

—

Revenue (TTM)

—

Trailing 12 months

EPS growth YoY

—

Shares change YoY

+12.6%

Year over year · more shares

Revenue CAGR (3Y)

—

Revenue CAGR (5Y)

—

EPS CAGR (3Y)

—

EPS CAGR (5Y)

—

FCF CAGR (3Y)

—

FCF CAGR (5Y)

—

Quality

14 metrics

Return on equity

-98.6%

Return on assets

-75.4%

Debt / equity

0.2

Current ratio

10.9

EBITDA (TTM)

—

Free cash flow (TTM)

−$338.91M

Quick ratio

10.9

Interest coverage

-55.2

Net debt / EBITDA

—

Return on invested capital

—

Trailing 12 months

Net cash

$423.93M

Latest balance sheet

Cash & equivalents

$48.88M

Total assets

$532.98M

Total debt

$75.23M

Cash flow & spend

7 metrics

Operating cash flow (TTM)

−$338.65M

Capital expenditures (TTM)

$258,000

R&D (TTM)

$261.87M

SG&A (TTM)

—

Stock compensation (TTM)

$49.78M

R&D / revenue

—

Stock compensation / revenue

—

Ownership (13F)

3 metrics

13F filers

221

13F filer change QoQ

-10

Institutional ownership

108.7%

Short interest

3 metrics

Short interest

23.3%

Latest settlement · 7.0 days to cover

Days to cover

7.0d

Short-squeeze score

70 / 100

Insider activity

2 metrics

Net insider buying (90D)

−$2.66M

Insider-sentiment score

—

Risk flags

1 metrics

Going concern

—

VERA · Vera Therapeutics, Inc.

VERA metrics

Market overview

Price action

Company

Valuation

Historical valuation

Dividends & buybacks

Earnings calendar

Profitability

Growth

Quality

Cash flow & spend

Ownership (13F)

Short interest

Insider activity

Risk flags

No metrics match that search